# Sight Sciences, Inc.: filings

SGHT · Nasdaq · CIK 1531177 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sght.md) · [Financials](/companies/sght/financials.md) · [Filings](/companies/sght/filings.md) · [Insiders](/companies/sght/insiders.md)

## Reports and events: 101 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 198, 144 122, 8-K 66, 3 25, 10-Q 16, D 6, SC 13G 6, 10-K 5, CORRESP 5, DEF 14A 5, DEFA14A 5, SCHEDULE 13G/A 5, SC 13G/A 4, SD 4, D/A 3, SC 13D/A 3, UPLOAD 3, 4/A 2, EFFECT 2, S-1/A 2, S-8 2, SC 13D 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-3 1, S-3/A 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 12:21 ET | [8-K](/filings/0001193125-26-341346.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-341346 |
| 2026-08-05 | 20:21 ET | [10-Q](/filings/0001193125-26-335204.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335204 |
| 2026-08-05 | 20:09 ET | [8-K](/filings/0001193125-26-335092.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-335092 |
| 2026-06-05 | 20:06 ET | [8-K](/filings/0001193125-26-259546.md) | 5.07 Shareholder vote results | 0001193125-26-259546 |
| 2026-05-06 | 20:30 ET | [10-Q](/filings/0001193125-26-209116.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209116 |
| 2026-05-06 | 20:08 ET | [8-K](/filings/0001193125-26-208959.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-208959 |
| 2026-04-23 | 12:01 ET | [8-K](/filings/0001193125-26-171887.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-171887 |
| 2026-04-22 | 20:36 ET | [DEF 14A](/filings/0001140361-26-016138.md) | Proxy statement, period 2026-06-04 | 0001140361-26-016138 |
| 2026-03-30 | 11:07 ET | [8-K](/filings/0001193125-26-130386.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-130386 |
| 2026-03-04 | 21:19 ET | [10-K](/filings/0001193125-26-091558.md) | Annual report, period 2025-12-31 | 0001193125-26-091558 |
| 2026-03-04 | 21:08 ET | [8-K](/filings/0001193125-26-091482.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-091482 |
| 2026-02-03 | 22:30 ET | [8-K](/filings/0001193125-26-035915.md) | 1.01 Entry into a material agreement | 0001193125-26-035915 |
| 2026-01-13 | 12:09 ET | [8-K](/filings/0001193125-26-011106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-011106 |
| 2025-11-06 | 21:19 ET | [10-Q](/filings/0001193125-25-269613.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269613 |
| 2025-11-06 | 21:11 ET | [8-K](/filings/0001193125-25-269525.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-269525 |
| 2025-10-17 | 11:05 ET | [8-K](/filings/0001193125-25-241948.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241948 |
| 2025-09-30 | 20:11 ET | [8-K](/filings/0001193125-25-225041.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-225041 |
| 2025-08-27 | 20:05 ET | [8-K](/filings/0001531177-25-000007.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001531177-25-000007 |
| 2025-08-07 | 20:19 ET | [10-Q](/filings/0000950170-25-105065.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105065 |
| 2025-08-07 | 20:09 ET | [8-K](/filings/0000950170-25-105012.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-105012 |
| 2025-06-05 | 20:46 ET | [8-K](/filings/0001193125-25-135930.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-135930 |
| 2025-05-08 | 20:16 ET | [10-Q](/filings/0000950170-25-067008.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067008 |
| 2025-05-08 | 20:08 ET | [8-K](/filings/0000950170-25-066935.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-066935 |
| 2025-04-23 | 21:08 ET | [DEF 14A](/filings/0001140361-25-015218.md) | Proxy statement, period 2025-06-05 | 0001140361-25-015218 |
| 2025-04-22 | 20:09 ET | [8-K](/filings/0000950170-25-056724.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-056724 |
| 2025-03-13 | 23:24 ET | [SCHEDULE 13D/A](/filings/0000950170-25-039015.md) | Ownership report, active investor, amended | 0000950170-25-039015 |
| 2025-03-07 | 21:08 ET | [10-K](/filings/0000950170-25-035500.md) | Annual report, period 2024-12-31 | 0000950170-25-035500 |
| 2025-03-05 | 21:08 ET | [8-K](/filings/0000950170-25-033556.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-033556 |
| 2025-01-28 | 21:15 ET | [8-K](/filings/0000950170-25-009820.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-009820 |
| 2025-01-14 | 13:10 ET | [8-K](/filings/0000950170-25-005104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-005104 |
| 2024-12-11 | 21:36 ET | [8-K](/filings/0000950170-24-135402.md) | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0000950170-24-135402 |
| 2024-11-07 | 21:24 ET | [10-Q](/filings/0000950170-24-123403.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123403 |
| 2024-11-07 | 21:11 ET | [8-K](/filings/0000950170-24-123336.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123336 |
| 2024-10-03 | 13:31 ET | [8-K](/filings/0000950170-24-112038.md) | 8.01 Other events | 0000950170-24-112038 |
| 2024-09-26 | 20:48 ET | [8-K](/filings/0000950170-24-109665.md) | 8.01 Other events | 0000950170-24-109665 |
| 2024-08-02 | 20:27 ET | [10-Q](/filings/0000950170-24-090008.md) | Quarterly report, period 2024-06-30 | 0000950170-24-090008 |
| 2024-08-01 | 20:10 ET | [8-K](/filings/0000950170-24-089277.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-089277 |
| 2024-06-07 | 22:46 ET | [8-K](/filings/0000950170-24-070062.md) | 5.07 Shareholder vote results | 0000950170-24-070062 |
| 2024-05-30 | 13:19 ET | [8-K](/filings/0000950170-24-066276.md) | 8.01 Other events | 0000950170-24-066276 |
| 2024-05-06 | 20:16 ET | [10-Q](/filings/0000950170-24-053572.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053572 |
| 2024-05-02 | 20:07 ET | [8-K](/filings/0000950170-24-052094.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-052094 |
| 2024-04-29 | 12:15 ET | [8-K](/filings/0001193125-24-120159.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-120159 |
| 2024-04-26 | 10:00 ET | [DEF 14A](/filings/0001140361-24-022158.md) | Proxy statement, period 2024-06-06 | 0001140361-24-022158 |
| 2024-03-13 | 23:32 ET | [10-K](/filings/0000950170-24-030278.md) | Annual report, period 2023-12-31 | 0000950170-24-030278 |
| 2024-03-07 | 21:15 ET | [8-K](/filings/0000950170-24-027971.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-027971 |
| 2024-02-02 | 21:02 ET | [8-K](/filings/0001193125-24-022830.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-022830 |
| 2024-01-23 | 21:07 ET | [8-K](/filings/0001193125-24-012979.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-012979 |
| 2023-12-18 | 22:13 ET | [8-K](/filings/0001193125-23-297713.md) | 1.01 Entry into a material agreement | 0001193125-23-297713 |
| 2023-12-07 | 21:51 ET | [8-K](/filings/0001193125-23-290749.md) | 8.01 Other events | 0001193125-23-290749 |
| 2023-12-01 | 21:05 ET | [SC 13D/A](/filings/0001193125-23-287443.md) | Ownership report, active investor, amended | 0001193125-23-287443 |

Page 1 of 3. [Older](/companies/sght/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.